EN

Case No COMP/M.6114 - 3i GROUP/ ONEMED

Only the English text is available and authentic.

REGULATION (EC) No 139/2004 MERGER PROCEDURE

Article 6(1)(b) NON-OPPOSITION Date: 24/02/2011

In electronic form on the EUR-Lex website under document number 32011M6114

Office for Publications of the European Union L-2985 Luxembourg

EUROPEAN COMMISSION

Brussels, 24.02.2011 SG-Greffe(2011) D/2851 C(2011) 1326 final

PUBLIC VERSION

MERGER PROCEDURE ARTICLE 6(1)(b) DECISION

SIMPLIFIED PROCEDURE

To the notifying party:

Dear Madam(s) and/or Sir(s),

Subject: Case No COMP/M.6114 - 3i GROUP/ ONEMED Notification of 20/01/2011 pursuant to Article 4 of Council Regulation (EC) No 139/2004 Publication in the Official Journal of the European Union No C 29, 29/01/2011, p. 26

1.On 20/01/2011, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which 3i Group (United Kingdom) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of OneMed Group Oy ("OneMed", Finland) by way of purchase of shares.

The business activities of the undertakings concerned are:

-- 3i Group: an international investor focused on private equity, infrastructure and debt management, investing in Europe, Asia and North America;

-- OneMed: a wholesaler focusing on selling medical consumables to private and public health care providers in Sweden, Finland, Poland, Denmark, Norway and the Baltic countries.

1OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision.

Commission européenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel - Belgium. Telephone: (32-2) 299 11 11.

2.After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004.

For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation.

For the Commission (Signed) Alexander ITALIANER Director General

2OJ C 56, 5.3.2005, p. 32.

2